The impact on sexual functioning of chemotherapy-induced menopause in women with breast cancer.
This article presents a comprehensive review and synthesis of empirical and conceptually based literature documenting the impact of chemotherapy-induced menopause on the sexual functioning of women with breast cancer. A literature search of the CINAHL, MEDLINE, and Psych Lit from 1980 to 1999 databases was undertaken. This literature was systematically assessed to determine key findings and conclusions. Two major themes were identified and are reported here: physical and psychological sequelae associated with altered sexual functioning. Recommendations and suggestions for further directions in research are identified.
Rogers
Megan
M
Cancer Clinical Services, Sir Charles Gairdner Hospital, Nedlands, WA, Australia. Megan.Rogers@health.wa.gov.au
Kristjanson
Linda J
LJ
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000451:nursing / Q000523:psychology*; D005260:Female; D006801:Humans; D008594:Menopause, Premature / Q000523:psychology*; D009859:Oncology Nursing; D011788:Quality of Life; D019529:Sexuality / Q000523:psychology*